| Literature DB >> 23635381 |
Estela López-Rocha1, Julio Juárez-Álvarez, Lina Riego-Ruiz, Leonor Enciso-Moreno, Francisco Ortega-Aguilar, Julián Hernández-Nieto, José A Enciso-Moreno, Rubén López-Revilla.
Abstract
BACKGROUND: Although epidemiologic and socioeconomic criteria and biomedical risk factors indicate high-priority for tuberculosis (TB) control in Mexico, molecular epidemiology studies of the disease in the country are scarce.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23635381 PMCID: PMC3651706 DOI: 10.1186/1756-0500-6-172
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Population density, PTB incidence and MTC isolates per sanitary jurisdiction (January 2006 to March 2010)
| I | 2 | 1,724.1 | 1,054,522 | 611.6 | 352 (26.3) | 7.9 | 39 (16.5) |
| II | 11 | 21,757.9 | 216,348 | 9.9 | 28 (2.1) | 3.0 | 8 (3.4) |
| III | 13 | 13,447.0 | 273,705 | 20.4 | 28 (2.1) | 2.4 | 3 (1.3) |
| IV | 12 | 12,410.1 | 239,800 | 19.3 | 122 (9.1) | 12.0 | 39 (16.5) |
| V | 9 | 8,900.0 | 372,945 | 41.9 | 329 (24.6) | 20.8 | 53 (22.4) |
| VI | 11 | 2,306.8 | 338,193 | 146.6 | 480 (35.8) | 33.4 | 95 (40.1) |
| Total | 58 | 60,545.9 | 2,495,513 | 41.2 | 1339 (100.0) | 12.6 | 237 (100.0) |
*MTC, Mycobacterium tuberculosis complex.
†PTB cases confirmed by positive acid-fast bacilli smear.
‡PTB cases per 100,000 inhabitants.
§MTC cultures recovered and analyzed by spoligotyping.
Figure 1Flow diagram indicating the PTB cases, the cultured, recovered and spoligotyped MTC isolates, and the statistical, geographic and genotypic analyses performed for this study.
Figure 2PTB incidence rates by jurisdiction and region. (A) Incidence rate by sanitary jurisdiction. Roman numerals followed by Arabic numerals indicate each one of the six sanitary jurisdictions of the state of San Luis Potosí and their corresponding PTB incidence rates (per 100,000 inhabitants) in 2008. (B) Regions of low (jurisdictions I, II and III), intermediate (jurisdictions IV and V), and high (Jurisdiction VI) incidence, with their corresponding rates.
Sociodemographic and clinical variables of the PTB cases in the low-, intermediate- and high-incidence regions of the state
| Number of PTB cases | 63 | 83 | 102 | 248 | --- |
| Sex | | | | | |
| Male | 40 (63.5) ‡ | 47 (56.6) | 68 (66.7) | 155 (62.5) | 0.670 |
| Female | 23 (36.5) | 36 (43.4) | 34 (33.3) | 93 (37.5) | 0.861 |
| Median age | | | | | |
| Years (range) | 45 (18–86) | 48 (15–80) | 55 (16–95) | 50 (15–95) | 0.031 |
| Occupation | | | | | |
| Farm worker | 15 (23.8) | 25 (30.1) | 43 (42.2) | 83 (33.5) | 0.116 |
| Housewife | 18 (28.6) | 31 (37.3) | 28 (27.5) | 77 (31.0) | 0.449 |
| Unemployed | 11 (17.5) | 12 (14.5) | 19 (18.6) | 42 (16.9) | 0.779 |
| Employee | 12 (19.0) | 4 (4.8) | 3 (2.9) | 19 (7.7) | 0.001 |
| Independent | 5 (7.9) | 8 (9.6) | 7 (6.9) | 20 (8.1) | 0.819 |
| Another | 2 (3.2) | 3 (3.6) | 2 (2.0) | 7 (2.8) | 0.779 |
| Formal education | | | | | |
| None | 13 (20.6) | 21 (25.3) | 36 (35.3) | 70 (28.2) | 0.522 |
| Incomplete primary | 21 (33.3) | 29 (34.9) | 33 (32.4) | 83 (33.5) | 0.638 |
| Primary | 16 (25.4) | 21 (25.3) | 20 (19.6) | 57 (23.0) | 0.951 |
| Secondary | 11 (17.5) | 12 (14.5) | 11 (10.8) | 34 (13.7) | 0.192 |
| College | 2 (3.2) | 0 (0) | 2 (2.0) | 4 (1.6) | 0.301 |
| Habitat | | | | | |
| Rural | 11 (17.5) | 45 (54.2) | 88 (86.3) | 144 (58.1) | < 0.001 |
| Urban | 52 (82.5) | 38 (45.8) | 14 (13.7) | 104 (41.9) | < 0.001 |
| Marginalization index | | | | | |
| Very high | 0 (0) | 9 (10.8) | 0 (0) | 9 (3.6) | < 0.001 |
| High | 12 (19) | 18 (21.7) | 102 (100.0) | 132 (53.2) | < 0.001 |
| Medium | 2 (3.2) | 33 (39.8) | 0 (0) | 35 (14.1) | < 0.001 |
| Low | 1 (1.6) | 23 (27.7) | 0 (0) | 24 (9.7) | < 0.001 |
| Very low | 48 (76.2) | 0 (0) | 0 (0) | 48 (19.4) | < 0.001 |
| Previous history of TB | | | | | |
| No | 59 (93.7) | 75 (90.4) | 90 (88.2) | 224 (90.3) | 0.951 |
| Yes | 4 (6.3) | 8 (9.6) | 12 (11.8) | 24 (9.7) | 0.549 |
| Contact with TB cases | | | | | |
| Yes | 8 (12.7) | 24 (28.9) | 29 (28.4) | 61 (24.6) | 0.086 |
| No | 55 (87.3) | 59 (71.1) | 73 (28.4) | 187 (75.4) | 0.449 |
| Concomitant disease | | | | | |
| None | 34 (54.0) | 37 (44.6) | 50 (49.0) | 121 (48.8) | 0.741 |
| Diabetes | 20 (31.7) | 19 (22.9) | 14 (13.7) | 53 (21.4) | 0.047 |
| Malnutrition | 4 (6.3) | 15 (18.1) | 22 (21.6) | 41 (16.5) | 0.061 |
| Alcoholism | 1 (1.6) | 7 (8.4) | 15 (14.7) | 23 (9.3) | 0.026 |
| HIV-AIDS | 4 (6.3) | 1 (1.2) | 0 (0) | 5 (2.0) | 0.017 |
| Other | 0 (0) | 4 (4.8) | 1 (1.0) | 5 (2.0) | 0.082 |
| Acid-fast bacilli smear | | | | | |
| Positive | 56 (88.9) | 78 (94.0) | 100 (98.0) | 234 (94.4) | 0.016 |
| Negative | 7 (11.1) | 5 (6.0) | 2 (2.0) | 14 (5.6) | 0.584 |
*Number of cases per 100,000 inhabitants in parenthesis.
†χ2. One-way ANOVA, for age difference.
‡Numbers in parenthesis are percentages between variable categories, except in the median age where they are ranges.
Figure 3Dendrogram, families and spoligotype patterns of the 109 MTC genotypes identified.M. tuberculosis isolates of the Euro-American lineage are indicated with smaller font labels and those of other lineages and M. bovis isolates are indicated with larger font labels and their spoligotype patterns enclosed in rectangles. SIT: Spoligo international type numbers from the SpolDB4 database. M. bovis spoligotype identifiers (marked with asterisks) from the Mbovis.org database.
Spoligotype patterns and octal codes of the 24 MTC clusters found
| c-24 | 53 | 68 | 1111111111111111111111111111111100001111111 | 777777777760771 |
| c-18 | 42 | 14 | 1111111111111111111100001111111100001111111 | 777777607760771 |
| c-10 | 20 | 7 | 1101111111111111111100001111111100001111111 | 677777607760771 |
| c-16 | 221 | 7 | 1111111111111101101111111111111100001111111 | 777766777760771 |
| c-21 | 239 | 6 | 1111111111111111111111111111111100000000111 | 777777777760031 |
| c-20 | 50 | 5 | 1111111111111111111111111111110100001111111 | 777777777720771 |
| c-22 | 787 | 5 | 1111111111111111111111111111111100000001111 | 777777777760071 |
| c-9 | 19 | 4 | 1101111111111111111001111111000010111111111 | 677777477413771 |
| c-12 | 2111 | 3 | 1110000011111111111111111111110100001111111 | 701777777720771 |
| c-1 | 1 | 3 | 0000000000000000000000000000000000111111111 | 000000000003771 |
| c-4 | 258 | 3 | 0000000000000000000011111111111100001111111 | 000000177760771 |
| c-8 | 17 | 3 | 1101111111110111111100001111111100001111111 | 677737607760771 |
| c-11 | --- | 2 | 1101111111111111111100111111111100001111111 | 677777637760771 |
| c-13 | 33 | 2 | 1111111100011111111100001111111100001111111 | 776177607760771 |
| c-14 | 37 | 2 | 1111111111110111111111111111111100001111111 | 777737777760771 |
| c-15 | --- | 2 | 1111111111111101101111111111111100001101111 | 777766777760671 |
| c-17 | 1277 | 2 | 1111111111111111110100001111111100001111111 | 777777207760771 |
| c-19 | 2070 | 2 | 1111111111111111111100111111111100001111111 | 777777637760771 |
| c-23 | 52 | 2 | 1111111111111111111111111111111100001110111 | 777777777760731 |
| c-2 | 2 | 2 | 0000000000000000000000001000000100001111111 | 000000004020771 |
| c-3 | 125 | 2 | 0000000000000000000000001111111100001110111 | 000000007760731 |
| c-6 | --- | 2 | 1100011111111111111111111111111100000000111 | 617777777760031 |
| c-7 | 194 | 2 | 1101111111110111111100001111111100001110111 | 677737607760731 |
| c-5 | --- | 2 | 1011011011011101111100111111111000001101111 | 555567637740671 |
*SIT, Spoligo international type number in SpolDB4.
†Number of isolates sharing the same spoligotype.
Figure 4Geographic distribution of the Euro-American and other MTC lineages found. (A) Distribution of the Euro-American lineage. (B) Distribution of the EAI, Beijing and Bovis lineages. The symbols indicate the localities with PTB cases associated to each lineage; the area of each circle is proportional to the number of cases per locality.
Lineages of the drug-resistant MTC isolates
| Euro-American | 8 (3.4%) | 1 (0.4%) | 2 (0.8%) | 9 (3.8%) | 20 (8.4%) |
| Indo-Oceanic (EAI) | 0 | 1 (0.4%) | 0 | 1 (0.4%) | 2 (0.8%) |
| East-Asian (Beijing) | 1 (0.4%) | 0 | 0 | 0 | 1 (0.4%) |
| Total | 9 (3.8) | 2 (0.8%) | 2 (0.8%) | 10 (4.2%) | 23 (9.7%) |
*Isolates resistant to one first line drug other than isoniazid or rifampicin.